Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)

(2012) Geoffrey D. Barnes et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

(2010) Renato D. Lopes et al.   AMERICAN HEART JOURNAL

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?

(2010) Peter J. Zimetbaum et al.   AMERICAN JOURNAL OF MEDICINE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation

(2010) Umberto Cucchini et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world

(2008) A. Meiltz et al.   EUROPACE